Share this post on:

decreasing concentration of L-Arginine. Alternatively, inclusion bodies were solubilized with 8 M urea and purified under denaturing conditions in the presence of 0.2% N-lauroylsarcosine. Proteins were then dialyzed against PBS, 0.2% N-lauroylsarcosine. Immunization and challenge of mice Five to seven-week-old female C57/BL6 mice were kept under specific pathogen-free conditions in a standardized 12 hours light/ dark cycle and received commercial food and water ad libitum. Before immunization on Day 0, 10 mL of blood was withdrawn from each mouse to prepare pre-immune serum samples. On days 0, 21 and 42, intranasal immunization of groups of 10 mice as controls with PBS or Intercell’s proprietary adjuvant IC31H and with the respective adjuvanted proteins was performed as follows: 17.5 mL (+)-Bicuculline protein solution was mixed with 2.5 mL IC31H, incubated for 30 minutes at room temperature and used to immunize mice within one hour of preparation. Adjuvant control mice received 17.5 mL 50 mM Tris/HCl pH 8.0 mixed with 2.5 mL IC31H. Immune sera were obtained on Day 63 and frozen at 220uC for storage. Twenty-one days after the last boost, mice were infected intranasally with 40 mL live M. catarrhalis strain RH4, equaling approximately 56106 CFU. For mouse inoculation, M. catarrhalis RH4 was grown in BHI broth to an OD620 of 0.4. Bacteria were pelleted and re-suspended in PBS. Mice were held in a head-up vertical position during the inoculation and kept in that position for at least 10 seconds after the inoculation. Euthanasia, tissue collection and bacterial culture Mice were euthanized at 6 hours post-infection. Both lungs were removed, placed in 1 mL PBS plus protease inhibitor, homogenized using cell strainers and used for serial plating to quantify viable bacteria. For the evaluation of bacterial clearance due to immunization with recombinant proteins, several independent experiments were performed and the CFU in the lungs of the mice were normalized to an infectious dose of approximately 56106 CFU bacteria and washed with PBS. The pellet was re-suspended in 100 mM Na2CO3 and sonicated on ice for 2 min. After centrifugation to remove cell debris, the supernatant was ultracentrifuged Protective Moraxella catarrhalis Antigens dose varied between 3.86 to 5.96106 CFU) and analyzed with non-parametric Kruskal-Wallis tests and Dunns post-testing. Preparation of M. catarrhalis lysates M. catarrhalis RH4 or BBH18 lysates were prepared from cultures grown in BHI broth. The cells were harvested, washed and re-suspended in PBS, then sonicated on ice using 2630 second bursts. 17496168 The protein concentration was measured using BCA protein assay reagent. Generation of the msp22 gene deletion mutant The M. catarrhalis gene deletion mutant msp22D was generated by amplifying a,500 bp 23321512 region up- and downstream of the msp22 gene from genomic DNA using the following oligonucleotide primers: 866659-TGATATTCGCTGAGATGTGA-39; 866759-CCACTAGTTCTAGAGCGGCAGTGTGGTTCTTGCCATAAG-39; 866859-GCGTCAATTCGAGGGGTATCTAAAACATGCAGCAGCTAAG-39; 866959-GATGGCATCATACCAATCTT-39. The flanking regions of the gene were ligated by overlap-extension PCR with a spectinomycin resistance cassette that was derived from the vector pR412T7. M. catarrhalis cells were rendered competent by washing with PBS containing 0.15% bovine gelatin. Transformation was achieved by adding the DNA fragments to the competent cell cultures, and subsequent plating on spectinomycin-containing blood agar plates. The numbers of CFU

Share this post on:

Author: calcimimeticagent